Caseware UK (AP4) 2025.0.111 2025.0.111 2026-03-312026-03-31true2falseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.2025-04-01falseNo description of principal activity2false 02700296 2025-04-01 2026-03-31 02700296 2024-04-01 2025-03-31 02700296 2026-03-31 02700296 2025-03-31 02700296 c:Director1 2025-04-01 2026-03-31 02700296 c:Director2 2025-04-01 2026-03-31 02700296 d:CurrentFinancialInstruments 2026-03-31 02700296 d:CurrentFinancialInstruments 2025-03-31 02700296 d:ShareCapital 2026-03-31 02700296 d:ShareCapital 2025-03-31 02700296 d:SharePremium 2026-03-31 02700296 d:SharePremium 2025-03-31 02700296 d:CapitalRedemptionReserve 2026-03-31 02700296 d:CapitalRedemptionReserve 2025-03-31 02700296 d:RetainedEarningsAccumulatedLosses 2026-03-31 02700296 d:RetainedEarningsAccumulatedLosses 2025-03-31 02700296 c:FRS102 2025-04-01 2026-03-31 02700296 c:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 02700296 c:FullAccounts 2025-04-01 2026-03-31 02700296 c:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 02700296 6 2025-04-01 2026-03-31 02700296 e:PoundSterling 2025-04-01 2026-03-31 iso4217:GBP xbrli:pure
Registered number: 02700296







UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 MARCH 2026


NICHE STRATEGIC HEALTH PARTNERS LTD







































 


NICHE STRATEGIC HEALTH PARTNERS LTD
REGISTERED NUMBER:02700296



STATEMENT OF FINANCIAL POSITION
AS AT 31 MARCH 2026

2026
2025
Note
£
£

Fixed assets
  

Investments
 4 
27,030
27,030

  
27,030
27,030

Current assets
  

Debtors: amounts falling due within one year
 5 
87,737
87,737

  
87,737
87,737

Total assets less current liabilities
  
 
 
114,767
 
 
114,767

Provisions for liabilities
  

Deferred tax
  
(2,117)
(2,117)

  
 
 
(2,117)
 
 
(2,117)

Net assets
  
112,650
112,650


Capital and reserves
  

Called up share capital 
  
54,060
54,060

Share premium account
  
46,492
46,492

Capital redemption reserve
  
11,623
11,623

Profit and loss account
  
475
475

  
112,650
112,650


Page 1

 


NICHE STRATEGIC HEALTH PARTNERS LTD
REGISTERED NUMBER:02700296


    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 MARCH 2026

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




J Fitton
K Jury
Director
Director


Date: 1 October 2026
Date:1 October 2026

The notes on pages 3 to 5 form part of these financial statements.

Page 2

 


NICHE STRATEGIC HEALTH PARTNERS LTD
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

1.


General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
4th Floor, Trafford House
Chester Road
Stretford
Manchester
M32 0RS

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

  
2.2

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value. 

  
2.3

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequenly measured at amortised cost using the effective interest method, less provison for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

  
2.4

Trade creditors

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of reporting period, to defer settlement of the creditor for at least twelve months after the reporting date, they are presented as non current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Page 3

 


NICHE STRATEGIC HEALTH PARTNERS LTD
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

2.Accounting policies (continued)

 
2.5

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:

The recognition of deferred tax assets is limited to the extent that it is probable that they wil be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.



Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.


 
2.6

Investments

Investments in equity shares which are publicly traded or where fair value can be measured reliably are initially measured at fiar value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment. 

Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

 
2.7

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.8

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

Page 4

 


NICHE STRATEGIC HEALTH PARTNERS LTD
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

2.Accounting policies (continued)

  
2.9

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present basis.


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2025 - 2).


4.


Investments





Investments in subsidiaries

£



Cost or valuation


At 1 April 2025
27,030



At 31 March 2026
27,030





5.


Debtors

2026
2025
£
£


Amounts owed by related parties
87,737
87,737

87,737
87,737


 
Page 5